title: Letter: Vedolizumab in Pregnancy.
authors.affiliation: Department of Gastroenterology and Centre for Colorectal Disease, St. Vincent's University Hospital, and School of Medicine, University College Dublin, Dublin, Ireland.
authors.forename: Juliette
authors.initials: J
authors.lastname: Sheridan
authors.affiliation: Department of Gastroenterology and Centre for Colorectal Disease, St. Vincent's University Hospital, and School of Medicine, University College Dublin, Dublin, Ireland.
authors.forename: Garret
authors.initials: G
authors.lastname: Cullen
authors.affiliation: Department of Gastroenterology and Centre for Colorectal Disease, St. Vincent's University Hospital, and School of Medicine, University College Dublin, Dublin, Ireland.
authors.forename: Glen
authors.initials: G
authors.lastname: Doherty
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D005765:Gastrointestinal Agents; C543529:vedolizumab